The decrease of particle-induced osteolysis after a single dose of bisphosphonate

Biomaterials

Volumn 26, Issue 14, 2005, Pages 1803-1808

  Von Knoch, Marius ^a   Wedemeyer, Christian ^a   Pingsmann, Andreas ^a   Von Knoch, Fabian ^b   Hilken, Gero ^a   Sprecher, Christoph ^c   Henschke, Frank ^d   Barden, Bertram ^a   Löer, Franz ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Raetisches Kantons Regionalspital ^*  (Switzerland)

^c AO RESEARCH INSTITUTE   (Switzerland)

^d Pathologisches Inst Am J   (Germany)

Author keywords

Osteoclast; Osteolysis; Particulates; Polyethylene; Wear debris

Indexed keywords

BONE; DRUG DOSAGE; IMPLANTS (SURGICAL); MATHEMATICAL MODELS; SURGERY;

JOINT REPLACEMENT; OSTEOLYSIS; PARTICLE IMPLANTATION; ZOLEDRONIC ACID (ZA);

JOINT PROSTHESES;

BISPHOSPHONIC ACID DERIVATIVE; PHOSPHONIC ACID DERIVATIVE; POLYETHYLENE; UNCLASSIFIED DRUG; ZOLEDRONIC ACID;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALVARIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; GIEMSA STAIN; MOUSE; NONHUMAN; OSTEOLYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STUDENT T TEST;

ANIMALS; BIOCOMPATIBLE MATERIALS; DIPHOSPHONATES; FEMALE; FOREIGN-BODY REACTION; IMIDAZOLES; INJECTIONS, SUBCUTANEOUS; MALE; MATERIALS TESTING; MICE; MICE, INBRED C57BL; OSTEOLYSIS; PARTICLE SIZE; POLYETHYLENE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ANIMALIA; MURINAE;

EID: 9644266509     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2004.06.010     Document Type: Article

References (20)

1. Silva M.J., Sandell L.J. What's new in orthopaedic research. J Bone Jt Surg Am. 84-A(8):2002;1490-1496
2. Kurtz S.M., Muratoglu O.K., Evans M., Edidin A.A. Advances in the processing, sterilization, and crosslinking of ultra-high molecular weight polyethylene for total joint arthroplasty. Biomaterials. 20(18):1999;1659-1688
3. Kwon YS, Maloney WJ, Bataractcha T, Clohisy J, Sung JH, Erdmann J, Teitelbaum SL. A simple animal model for particulate debris-induced osteolysis using mouse calvarium. 46th Annual Meeting, Orthopaedic Research Society, Orlando, FL, March 12-15, 2000.
4. Willert H.G., Bertram H., Buchhorn G.H. Osteolysis in alloarthroplasty of the hip. The role of ultra-high molecular weight polyethylene wear particles. Clin Orthop. 258:1990;95-107
5. Willert H.G., Broback L.G., Buchhorn G.H., Jensen P.H., Koster G., Lang I., Ochsner P., Schenk R. Crevice corrosion of cemented titanium alloy stems in total hip replacements. Clin Orthop. 333:1996;51-75
6. Shanbhag A.S., Hasselman C.T., Rubash H.E. The John Charnley Award. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model. Clin Orthop. 344:1997;33-43
7. Millett P.J., Allen M.J., Bostrom M.P. Effects of alendronate on particle-induced osteolysis in a rat model. J Bone Jt Surg Am. 84-A(2):2002;236-249
8. Venesmaa P.K. Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty. a prospective randomized study J Bone Miner Res. 16:2001;2126-2131
9. Schwarz E.M., Lu A.P., Goater J.J., Benz E.B., Kollias G., Rosier R.N., Puzas J.E., O'Keefe R.J. Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis. J Orthop Res. 18(3):2000;472-480
10. Green J.R., Müller K., Jaeggi K.A. Preclinical pharmacology of CGP 42′446, a potent, heterocyclic bisphosphonate compound. J Bone Miner Res. 9:1994;745-751
11. Cheer S.M., Noble S. Zoledronic acid. Drugs. 61(6):2001;799-805
12. Sprecher C., Wimmer M.A. Size independent morphological description of polyethylene particles. J Biomech. 34:2001;S71
13. Childs L.M., Goater J.J., O'Keefe R.J., Schwarz E.M. Effect of anti-tumor necrosis factor-alpha gene therapy on wear debris-induced osteolysis. J Bone Jt Surg Am. 83-A(12):2001;1789-1797
14. Liu C.C., Sherrard D.J., Maloney N.A., Howard G.A. Reactivation of inhibited bone acid phosphatase and its significance in bone histomorphometry. J Histochem Cytochem. 35(12):1987;1355-1363
15. Reid I.R., Brown J.P., Burckhardt P., Horowitz Z., Richardson P., Trechsel U., Widmer A., Devogelaer J.P., Kaufman J.M., Jaeger P., Body J.J., Brandi M.L., Broell J., Di Micco R., Genazzani A.R., Felsenberg D., Happ J., Hooper M.J., Ittner J., Leb G., Mallmin H., Murray T., Ortolani S., Rubinacci A., Saaf M., Samsioe G., Verbruggen L., Meunier P.J. Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med. 346(9):2002;653-661
16. Sato M., Grasser W., Endo N., et al. Bisphosphonate action. alendronate localization in rat bone and effects on osteoclast ultrastructure J Clin Invest. 88:1991;2095-2105
17. Masarachia P., Weinreb M., Balena R., Rodan G.A. Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones. Bone. 19:1996;281-290
18. Plotkin L.I., Weinstein R.S., Parfitt A.M., Roberson P.K., Manolagas S.C., Bellido T. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest. 104:1999;1363-1374
19. Reinholz G.G., Getz B., Pederson L., et al. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res. 60:2000;6001-6007
20. Iwase M., Kim K.J., Kobayashi Y., Itoh M., Itoh T. A novel bisphosphonate inhibits inflammatory bone resorption in a rat osteolysis model with continuous infusion of polyethylene particles. J Orthop Res. 20(3):2002;499-505